FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311587513> ?p ?o ?g. }

• W4311587513 abstract "Abstract The treatment landscape for relapsed multiple myeloma (MM) has increased. In this study, we aimed to characterize 2nd ( n = 1439) and 3rd ( n = 1104) line regimens and compare the results between subgroups based on the year of treatment initiation (2nd line: 2003–2008, 2009–2015, 2016–2021; 3rd line: 2004–2009, 2010–2015, and 2016–2021). In both the second- and third- lines, we observed increasing use of novel agents (from 78 to 95% and from 77 to 95%, respectively) and triplet regimens (from 15 to 69% and from 21 to 71%, respectively). The most frequently used regimens in the last studied periods included lenalidomide-dexamethasone (RD; 14%), carfilzomib-RD (12%), and daratumumab-RD (10%) for the second-line, and daratumumab-pomalidomide-dexamethasone (11%) and daratumumab-RD (10%) for the third-line. The median time to the next treatment from second-line therapy has improved from 10.4 months (95% CI: 8.4–12.4) to 16.6 months (95% CI: 13.3–20.3; p < 0.001). The median overall survival from the first relapse increased from 30.9 months (95% CI: 26.8–183.0) to 65.8 months (95% CI: 50.7–72.8; p < 0.001). Over the last two decades, more patients were treated with newer agents and triplets for relapsed MM. The landscape of regimens has become more diverse, and survival after the first relapse is continually improving." @default.
• W4311587513 created "2022-12-27" @default.
• W4311587513 creator A5000308170 @default.
• W4311587513 creator A5001453763 @default.
• W4311587513 creator A5002248011 @default.
• W4311587513 creator A5007747233 @default.
• W4311587513 creator A5012403700 @default.
• W4311587513 creator A5016853434 @default.
• W4311587513 creator A5023193953 @default.
• W4311587513 creator A5026574827 @default.
• W4311587513 creator A5033220547 @default.
• W4311587513 creator A5036263492 @default.
• W4311587513 creator A5056260546 @default.
• W4311587513 creator A5066940168 @default.
• W4311587513 creator A5068637846 @default.
• W4311587513 creator A5071965755 @default.
• W4311587513 creator A5074505099 @default.
• W4311587513 creator A5076611748 @default.
• W4311587513 creator A5077686486 @default.
• W4311587513 date "2022-12-06" @default.
• W4311587513 modified "2023-10-08" @default.
• W4311587513 title "Second- and third-line treatment strategies in multiple myeloma: a referral-center experience" @default.
• W4311587513 cites W2020298011 @default.
• W4311587513 cites W2083365324 @default.
• W4311587513 cites W2091773528 @default.
• W4311587513 cites W2121283512 @default.
• W4311587513 cites W2123159083 @default.
• W4311587513 cites W2128192762 @default.
• W4311587513 cites W2318069817 @default.
• W4311587513 cites W2402003835 @default.
• W4311587513 cites W2528979204 @default.
• W4311587513 cites W2529434198 @default.
• W4311587513 cites W2803026749 @default.
• W4311587513 cites W2890161608 @default.
• W4311587513 cites W2890436368 @default.
• W4311587513 cites W2945852816 @default.
• W4311587513 cites W3013063217 @default.
• W4311587513 cites W3043410628 @default.
• W4311587513 cites W3091008757 @default.
• W4311587513 cites W3134103265 @default.
• W4311587513 cites W2013651845 @default.
• W4311587513 doi "https://doi.org/10.1038/s41408-022-00757-8" @default.
• W4311587513 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36473843" @default.
• W4311587513 hasPublicationYear "2022" @default.
• W4311587513 type Work @default.
• W4311587513 citedByCount "1" @default.
• W4311587513 countsByYear W43115875132023 @default.
• W4311587513 crossrefType "journal-article" @default.
• W4311587513 hasAuthorship W4311587513A5000308170 @default.
• W4311587513 hasAuthorship W4311587513A5001453763 @default.
• W4311587513 hasAuthorship W4311587513A5002248011 @default.
• W4311587513 hasAuthorship W4311587513A5007747233 @default.
• W4311587513 hasAuthorship W4311587513A5012403700 @default.
• W4311587513 hasAuthorship W4311587513A5016853434 @default.
• W4311587513 hasAuthorship W4311587513A5023193953 @default.
• W4311587513 hasAuthorship W4311587513A5026574827 @default.
• W4311587513 hasAuthorship W4311587513A5033220547 @default.
• W4311587513 hasAuthorship W4311587513A5036263492 @default.
• W4311587513 hasAuthorship W4311587513A5056260546 @default.
• W4311587513 hasAuthorship W4311587513A5066940168 @default.
• W4311587513 hasAuthorship W4311587513A5068637846 @default.
• W4311587513 hasAuthorship W4311587513A5071965755 @default.
• W4311587513 hasAuthorship W4311587513A5074505099 @default.
• W4311587513 hasAuthorship W4311587513A5076611748 @default.
• W4311587513 hasAuthorship W4311587513A5077686486 @default.
• W4311587513 hasBestOaLocation W43115875131 @default.
• W4311587513 hasConcept C126322002 @default.
• W4311587513 hasConcept C143998085 @default.
• W4311587513 hasConcept C2776063141 @default.
• W4311587513 hasConcept C2776135927 @default.
• W4311587513 hasConcept C2776364478 @default.
• W4311587513 hasConcept C2778524551 @default.
• W4311587513 hasConcept C2780108899 @default.
• W4311587513 hasConcept C2780401358 @default.
• W4311587513 hasConcept C2781119759 @default.
• W4311587513 hasConcept C512399662 @default.
• W4311587513 hasConcept C71924100 @default.
• W4311587513 hasConceptScore W4311587513C126322002 @default.
• W4311587513 hasConceptScore W4311587513C143998085 @default.
• W4311587513 hasConceptScore W4311587513C2776063141 @default.
• W4311587513 hasConceptScore W4311587513C2776135927 @default.
• W4311587513 hasConceptScore W4311587513C2776364478 @default.
• W4311587513 hasConceptScore W4311587513C2778524551 @default.
• W4311587513 hasConceptScore W4311587513C2780108899 @default.
• W4311587513 hasConceptScore W4311587513C2780401358 @default.
• W4311587513 hasConceptScore W4311587513C2781119759 @default.
• W4311587513 hasConceptScore W4311587513C512399662 @default.
• W4311587513 hasConceptScore W4311587513C71924100 @default.
• W4311587513 hasIssue "12" @default.
• W4311587513 hasLocation W43115875131 @default.
• W4311587513 hasLocation W43115875132 @default.
• W4311587513 hasLocation W43115875133 @default.
• W4311587513 hasLocation W43115875134 @default.
• W4311587513 hasLocation W43115875135 @default.
• W4311587513 hasOpenAccess W4311587513 @default.
• W4311587513 hasPrimaryLocation W43115875131 @default.
• W4311587513 hasRelatedWork W1197848312 @default.
• W4311587513 hasRelatedWork W2147612932 @default.
• W4311587513 hasRelatedWork W2302708051 @default.
• W4311587513 hasRelatedWork W2478188943 @default.

• next